Detalhe da pesquisa
1.
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium.
Blood
; 139(12): 1785-1793, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192312
2.
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols.
Haematologica
; 105(7): 1887-1894, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601692
3.
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.
Ann Hematol
; 99(4): 809-818, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078009
4.
Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia.
Blood
; 134(8): 713-716, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31311816
5.
Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia.
Leukemia
; 35(9): 2650-2657, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33714975
6.
Larotrectinib in TRK fusion-positive pediatric B-cell acute lymphoblastic leukemia.
Blood Adv
; 3(22): 3499-3502, 2019 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31725893